Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (141-150 of 596) with videos related to

Pageof 60
Sort By:
Cytometry. Part B, Clinical Cytometry|January 4, 2013
Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasmsWolfgang Kern, Ulrike Bacher, Susanne Schnittger, et al.
Experimental Hematology|September 25, 2013
Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphomaUlrike Bacher, Wolfgang Kern, Claudia Haferlach, et al.
Cancer Genetics|April 15, 2014
Amplification of EVI1 on cytogenetically cryptic double minutes as new mechanism for increased expression of EVI1Sarah Volkert, Susanne Schnittger, Melanie Zenger, et al.
Leukemia & Lymphoma|March 20, 2020
Prognosis of <i>MECOM</i> (<i>EVI1</i>)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast countIsolde Summerer, Claudia Haferlach, Manja Meggendorfer, et al.
British Journal of Haematology|April 19, 2011
Ganglioneuroblastoma infiltrating the bone marrow in an adultUlrike Bacher, Maximilian Christopeit, Bettina Wiedemann, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 4, 2004
Gene expression profiling as a diagnostic tool in acute myeloid leukemiaWolfgang Kern, Alexander Kohlmann, Susanne Schnittger, et al.
Cancer Genetics and Cytogenetics|January 29, 2005
Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progressionUlrike Bacher, Torsten Haferlach, Wolfgang Hiddemann, et al.
Seminars in Hematology|October 29, 2003
Gene expression profiling as a tool for the diagnosis of acute leukemiasTorsten Haferlach, Alexander Kohlmann, Wolfgang Kern, et al.
Leukemia Research|May 5, 2012
Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical courseUlrike Bacher, Wolfgang Kern, Tamara Alpermann, et al.
British Journal of Haematology|July 26, 2002
Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patientsTorsten Haferlach, Claudia Schoch, Susanne Schnittger, et al.
Pageof 60

Showing results (141-150 of 596) with videos related to

Sort By:
Pageof 60
Cytometry. Part B, Clinical Cytometry|January 4, 2013
Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasmsWolfgang Kern, Ulrike Bacher, Susanne Schnittger, et al.
Experimental Hematology|September 25, 2013
Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphomaUlrike Bacher, Wolfgang Kern, Claudia Haferlach, et al.
Cancer Genetics|April 15, 2014
Amplification of EVI1 on cytogenetically cryptic double minutes as new mechanism for increased expression of EVI1Sarah Volkert, Susanne Schnittger, Melanie Zenger, et al.
Leukemia & Lymphoma|March 20, 2020
Prognosis of <i>MECOM</i> (<i>EVI1</i>)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast countIsolde Summerer, Claudia Haferlach, Manja Meggendorfer, et al.
British Journal of Haematology|April 19, 2011
Ganglioneuroblastoma infiltrating the bone marrow in an adultUlrike Bacher, Maximilian Christopeit, Bettina Wiedemann, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 4, 2004
Gene expression profiling as a diagnostic tool in acute myeloid leukemiaWolfgang Kern, Alexander Kohlmann, Susanne Schnittger, et al.
Cancer Genetics and Cytogenetics|January 29, 2005
Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progressionUlrike Bacher, Torsten Haferlach, Wolfgang Hiddemann, et al.
Seminars in Hematology|October 29, 2003
Gene expression profiling as a tool for the diagnosis of acute leukemiasTorsten Haferlach, Alexander Kohlmann, Wolfgang Kern, et al.
Leukemia Research|May 5, 2012
Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical courseUlrike Bacher, Wolfgang Kern, Tamara Alpermann, et al.
British Journal of Haematology|July 26, 2002
Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patientsTorsten Haferlach, Claudia Schoch, Susanne Schnittger, et al.
Pageof 60